<?xml version='1.0' encoding='utf-8'?>
<document id="26370539"><sentence text="Organic Anion Transporter 1 Is Inhibited by Multiple Mechanisms and Shows a Transport Mode Independent of Exchange." /><sentence text="The mechanism by which drugs inhibit organic anion transporter 1 (OAT1) was examined" /><sentence text=" OAT1 was stably expressed in Chinese hamster ovary (CHO) cells, and para-aminohippurate (PAH) and 6-carboxyfluorescein were the substrates"><entity charOffset="69-88" id="DDI-PubMed.26370539.s3.e0" text="para-aminohippurate" /><entity charOffset="90-93" id="DDI-PubMed.26370539.s3.e1" text="PAH" /><entity charOffset="99-119" id="DDI-PubMed.26370539.s3.e2" text="6-carboxyfluorescein" /><pair ddi="false" e1="DDI-PubMed.26370539.s3.e0" e2="DDI-PubMed.26370539.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26370539.s3.e0" e2="DDI-PubMed.26370539.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26370539.s3.e0" e2="DDI-PubMed.26370539.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26370539.s3.e1" e2="DDI-PubMed.26370539.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26370539.s3.e1" e2="DDI-PubMed.26370539.s3.e2" /></sentence><sentence text=" Most compounds (10 of 14) inhibited competitively, increasing the Michaelis constant (Km) without affecting the maximal transport rate (Jmax)" /><sentence text=" Others were mixed-type (lowering Jmax and increasing Km) or noncompetitive (lowering Jmax only) inhibitors" /><sentence text=" The interaction of a noncompetitive inhibitor (telmisartan) with OAT1 was examined further"><entity charOffset="48-59" id="DDI-PubMed.26370539.s6.e0" text="telmisartan" /></sentence><sentence text=" Binding of telmisartan to OAT1 was observed, but translocation was not"><entity charOffset="12-23" id="DDI-PubMed.26370539.s7.e0" text="telmisartan" /></sentence><sentence text=" Telmisartan did not alter the plasma membrane expression of OAT1, indicating that it lowers Jmax by reducing the turnover number"><entity charOffset="1-12" id="DDI-PubMed.26370539.s8.e0" text="Telmisartan" /></sentence><sentence text=" PAH transport after telmisartan treatment and its washout recovered faster in the presence of 10% fetal bovine serum in the washout buffer, indicating that binding of telmisartan to OAT1 and its inhibitory effect are reversible"><entity charOffset="21-32" id="DDI-PubMed.26370539.s9.e0" text="telmisartan" /><entity charOffset="168-179" id="DDI-PubMed.26370539.s9.e1" text="telmisartan" /><entity charOffset="1-11" id="DDI-PubMed.26370539.s9.e2" text="PAH" /><pair ddi="false" e1="DDI-PubMed.26370539.s9.e2" e2="DDI-PubMed.26370539.s9.e2" /><pair ddi="false" e1="DDI-PubMed.26370539.s9.e2" e2="DDI-PubMed.26370539.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26370539.s9.e2" e2="DDI-PubMed.26370539.s9.e1" /><pair ddi="false" e1="DDI-PubMed.26370539.s9.e0" e2="DDI-PubMed.26370539.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26370539.s9.e0" e2="DDI-PubMed.26370539.s9.e1" /></sentence><sentence text=" Together, these data suggest that telmisartan binds reversibly to a site distinct from substrate and stabilizes the transporter in a conformation unfavorable for translocation"><entity charOffset="35-46" id="DDI-PubMed.26370539.s10.e0" text="telmisartan" /></sentence><sentence text=" In the absence of an exchangeable extracellular substrate, PAH efflux from CHO-OAT1 cells was relatively rapid"><entity charOffset="60-70" id="DDI-PubMed.26370539.s11.e0" text="PAH" /></sentence><sentence text=" Telmisartan slowed PAH efflux, suggesting that some transporter-mediated efflux occurs independent of exchange"><entity charOffset="1-12" id="DDI-PubMed.26370539.s12.e0" text="Telmisartan" /><entity charOffset="20-30" id="DDI-PubMed.26370539.s12.e1" text="PAH" /><pair ddi="false" e1="DDI-PubMed.26370539.s12.e0" e2="DDI-PubMed.26370539.s12.e0" /><pair ddi="false" e1="DDI-PubMed.26370539.s12.e0" e2="DDI-PubMed.26370539.s12.e1" /></sentence><sentence text=" Although drug-drug interaction predictions at OAT1 assume competitive inhibition, these data show that OAT1 can be inhibited by other mechanisms, which could influence the accuracy of drug-drug interaction predictions at the transporter" /><sentence text=" Telmisartan was useful for examining how a noncompetitive inhibitor can alter OAT1 transport activity and for uncovering a transport mode independent of exchange"><entity charOffset="1-12" id="DDI-PubMed.26370539.s14.e0" text="Telmisartan" /></sentence><sentence text=" " /></document>